198 related articles for article (PubMed ID: 31536933)
21. Combination of Solamargine and Metformin Strengthens IGFBP1 Gene Expression Through Inactivation of Stat3 and Reciprocal Interaction Between FOXO3a and SP1.
Tang Q; Zheng F; Wu J; Xiao Q; Li L; Hann SS
Cell Physiol Biochem; 2017; 43(6):2310-2326. PubMed ID: 29073599
[TBL] [Abstract][Full Text] [Related]
22. IQGAP1 binds ERK2 and modulates its activity.
Roy M; Li Z; Sacks DB
J Biol Chem; 2004 Apr; 279(17):17329-37. PubMed ID: 14970219
[TBL] [Abstract][Full Text] [Related]
23. Sp1 coordinately regulates de novo lipogenesis and proliferation in cancer cells.
Lu S; Archer MC
Int J Cancer; 2010 Jan; 126(2):416-25. PubMed ID: 19621387
[TBL] [Abstract][Full Text] [Related]
24. The oncoprotein HBXIP activates transcriptional coregulatory protein LMO4 via Sp1 to promote proliferation of breast cancer cells.
Yue L; Li L; Liu F; Hu N; Zhang W; Bai X; Li Y; Zhang Y; Fu L; Zhang X; Ye L
Carcinogenesis; 2013 Apr; 34(4):927-35. PubMed ID: 23291272
[TBL] [Abstract][Full Text] [Related]
25. IQGAP1 modulates the proliferation and invasion of thyroid cancer cells in response to estrogen.
Meng D; Wu W; Li Z; Qin G
Int J Mol Med; 2015 Aug; 36(2):588-94. PubMed ID: 26046126
[TBL] [Abstract][Full Text] [Related]
26. RhoC protein stimulates migration of gastric cancer cells through interaction with scaffold protein IQGAP1.
Wu Y; Chen YC; Sang JR; Xu WR
Mol Med Rep; 2011; 4(4):697-703. PubMed ID: 21537845
[TBL] [Abstract][Full Text] [Related]
27. Differential regulation of MAGE-A1 promoter activity by BORIS and Sp1, both interacting with the TATA binding protein.
Schwarzenbach H; Eichelser C; Steinbach B; Tadewaldt J; Pantel K; Lobanenkov V; Loukinov D
BMC Cancer; 2014 Nov; 14():796. PubMed ID: 25363021
[TBL] [Abstract][Full Text] [Related]
28. Attenuation of c-Jun and Sp1 expression and p300 recruitment to gene promoter confers the trichostatin A-induced inhibition of 12(S)-lipoxygenase expression in EGF-treated A431 cells.
Chen CJ; Chang WC; Chen BK
Eur J Pharmacol; 2008 Sep; 591(1-3):36-42. PubMed ID: 18590721
[TBL] [Abstract][Full Text] [Related]
29. USO1 promotes tumor progression via activating Erk pathway in multiple myeloma cells.
Jin Y; Dai Z
Biomed Pharmacother; 2016 Mar; 78():264-271. PubMed ID: 26898451
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of integrin-linked kinase expression by emodin through crosstalk of AMPKα and ERK1/2 signaling and reciprocal interplay of Sp1 and c-Jun.
Tang Q; Zhao S; Wu J; Zheng F; Yang L; Hu J; Hann SS
Cell Signal; 2015 Jul; 27(7):1469-77. PubMed ID: 25889897
[TBL] [Abstract][Full Text] [Related]
31. Sp1, acetylated histone-3 and p300 regulate TRAIL transcription: mechanisms of PDGF-BB-mediated VSMC proliferation and migration.
Azahri NS; Di Bartolo BA; Khachigian LM; Kavurma MM
J Cell Biochem; 2012 Aug; 113(8):2597-606. PubMed ID: 22415975
[TBL] [Abstract][Full Text] [Related]
32. Constitutively phosphorylated Smad3 interacts with Sp1 and p300 in scleroderma fibroblasts.
Ihn H; Yamane K; Asano Y; Jinnin M; Tamaki K
Rheumatology (Oxford); 2006 Feb; 45(2):157-65. PubMed ID: 16319104
[TBL] [Abstract][Full Text] [Related]
33. Ligand activated hPR modulates the glycodelin promoter activity through the Sp1 sites in human endometrial adenocarcinoma cells.
Gao J; Mazella J; Seppala M; Tseng L
Mol Cell Endocrinol; 2001 May; 176(1-2):97-102. PubMed ID: 11369448
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the role of Sp1 and NF-Y in differential regulation of PTTG/securin expression in tumor cells.
Clem AL; Hamid T; Kakar SS
Gene; 2003 Dec; 322():113-21. PubMed ID: 14644503
[TBL] [Abstract][Full Text] [Related]
35. IQGAP1 promotes cell proliferation and is involved in a phosphorylation-dependent manner in wound closure of bronchial epithelial cells.
Wang Y; Wang M; Wang F; Zhu M; Ma Y; Wang X; Wu R
Int J Mol Med; 2008 Jul; 22(1):79-87. PubMed ID: 18575779
[TBL] [Abstract][Full Text] [Related]
36. The Ras GTPase-activating-like protein IQGAP1 is downregulated in human diabetic nephropathy and associated with ERK1/2 pathway activation.
Zhou H; Yao C; Bian A; Qian J; Zhao X; Zhao Y; Wang W; Xing C
Mol Cell Biochem; 2014 Jun; 391(1-2):21-5. PubMed ID: 24488174
[TBL] [Abstract][Full Text] [Related]
37. LPS depletes PHLPP levels in macrophages through the inhibition of SP1 dependent transcriptional regulation.
Alamuru-Yellapragada NP; Vundyala S; Behera S; Parsa KV
Biochem Biophys Res Commun; 2017 Apr; 486(2):533-538. PubMed ID: 28322791
[TBL] [Abstract][Full Text] [Related]
38. Significant biological role of sp1 transactivation in multiple myeloma.
Fulciniti M; Amin S; Nanjappa P; Rodig S; Prabhala R; Li C; Minvielle S; Tai YT; Tassone P; Avet-Loiseau H; Hideshima T; Anderson KC; Munshi NC
Clin Cancer Res; 2011 Oct; 17(20):6500-9. PubMed ID: 21856768
[TBL] [Abstract][Full Text] [Related]
39. The Effects of Proteasome Inhibitors on Telomerase Activity and Regulation in Multiple Myeloma Cells.
Shalem-Cohavi N; Beery E; Nordenberg J; Rozovski U; Raanani P; Lahav M; Uziel O
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31117293
[TBL] [Abstract][Full Text] [Related]
40. Identification of Critical Elements for Regulation of Inorganic Pyrophosphatase (PPA1) in MCF7 Breast Cancer Cells.
Mishra DR; Chaudhary S; Krishna BM; Mishra SK
PLoS One; 2015; 10(4):e0124864. PubMed ID: 25923237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
